The US Food and Drug Administration (FDA) has approved a product known as enzalutamide (Xtandi®) to be used in a new way. The body, after an in-depth review says that it is ideal for handling a condition called prostate cancer (mHSPC). A close outlook Sometime back, the company gave its approval to the product for […]
Michael Jung
Recent Posts
Healixa Expands Advisory Board with Appointment of Accomplished C-Level Executive with History of Accelerating Profitable Growth
Kona Gold Beverage, Inc Partners with Strategy & Execution Inc to Accelerate Beverage Growth in 2023
Titan NRG, Inc. (TTNN) Releases 2022 Quarterly Report With 23% Revenue Increase Over Same Quarter 2021
Wanderport Corporation Announces Execution of Definitive Agreement with OZ Leather JSC to Enter the Automotive Sector
ZICIX AND ASIA BASED CONSTRUCTION GROUP AGREES TO FORM A CONSTRUCTION MANAGEMENT COMPANY
Popular Post
-
Japanese Premier Declares COVID-19 State of Emergency in Tokyo
-
Buscar Company has completed the acquisition of APTG Inc., a Solar Concentrated Power technology company
-
Google Gives Spotify its Own In-App Payment Option as Part of a New Pilot
-
Toyota Suspends Production at 2 Plants in Japan Citing Chip Shortage
-
China Unveils Maglev Train With a Top Speed of 600 kph
